Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析

◆英語タイトル:Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME6FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zimmer Biomet Holdings Inc (ZBH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs, manufactures, and markets orthopaedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, craniomaxillofacial and thoracic products; office based technologies; dental implants; and related surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries in bones, joints and supporting soft tissues. Zimmer Biomet offers products to orthopaedic surgeons, oral surgeons, neurosurgeons, other specialists, dentists, stocking distributors, hospitals, healthcare dealers and healthcare purchasing organizations. The company markets products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.

Zimmer Biomet Holdings Inc Key Recent Developments

Mar 03,2021: PrecisionOS to showcase collaboration with Zimmer Biomet
Feb 22,2021: Zimmer Biomet announces Changes to Company’s Board of Directors
Feb 16,2021: Vafa Jamali Appointed as CEO of “NewCo”, New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet
Feb 10,2021: Zimmer Biomet to Present at Citi’s 2021 Healthcare Services, Medtech, Tools, and HCIT Virtual Conference
Feb 05,2021: Zimmer Biomet announces fourth quarter and full-year 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Zimmer Biomet Holdings Inc – Key Facts
Zimmer Biomet Holdings Inc – Key Employees
Zimmer Biomet Holdings Inc – Key Employee Biographies
Zimmer Biomet Holdings Inc – Major Products and Services
Zimmer Biomet Holdings Inc – History
Zimmer Biomet Holdings Inc – Company Statement
Zimmer Biomet Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Zimmer Biomet Holdings Inc – Business Description
Product Category: Dental, Spine & CMF
Overview
Performance
Product Category: Hips
Overview
Performance
Product Category: Knees
Overview
Performance
Product Category: Other
Overview
Performance
Product Category: S.E.T
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Zimmer Biomet Holdings Inc – Corporate Strategy
Zimmer Biomet Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
Zimmer Biomet Holdings Inc – Strengths
Zimmer Biomet Holdings Inc – Weaknesses
Zimmer Biomet Holdings Inc – Opportunities
Zimmer Biomet Holdings Inc – Threats
Zimmer Biomet Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Zimmer Biomet Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 03, 2021: PrecisionOS to showcase collaboration with Zimmer Biomet
Feb 22, 2021: Zimmer Biomet announces Changes to Company’s Board of Directors
Feb 16, 2021: Vafa Jamali Appointed as CEO of “NewCo”, New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet
Feb 10, 2021: Zimmer Biomet to Present at Citi’s 2021 Healthcare Services, Medtech, Tools, and HCIT Virtual Conference
Feb 05, 2021: Zimmer Biomet announces fourth quarter and full-year 2020 financial results
Feb 05, 2021: Zimmer Biomet announces intent to spin off spine and dental businesses
Jan 21, 2021: Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance
Jan 19, 2021: Zimmer Biomet appoints Ellison M. Humphrey as Chief Transformation Officer
Dec 16, 2020: Zimmer Biomet announces quarterly dividend for fourth quarter of 2020
Dec 01, 2020: Zimmer Biomet Foundation launches, supporting diverse and underserved communities, STEM education, community health and disaster relief
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Zimmer Biomet Holdings Inc, Key Facts
Zimmer Biomet Holdings Inc, Key Employees
Zimmer Biomet Holdings Inc, Key Employee Biographies
Zimmer Biomet Holdings Inc, Major Products and Services
Zimmer Biomet Holdings Inc, History
Zimmer Biomet Holdings Inc, Subsidiaries
Zimmer Biomet Holdings Inc, Key Competitors
Zimmer Biomet Holdings Inc, Ratios based on current share price
Zimmer Biomet Holdings Inc, Annual Ratios
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...1)
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...2)
Zimmer Biomet Holdings Inc, Interim Ratios
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Zimmer Biomet Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cardiac Science Corp:企業の戦略的SWOT分析
    Cardiac Science Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Janssen Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a pharmaceutical company that develops drugs. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental health, neurolog …
  • ICBC Standard Bank Plc:企業の戦略・SWOT・財務情報
    ICBC Standard Bank Plc - Strategy, SWOT and Corporate Finance Report Summary ICBC Standard Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NxStage Medical Inc:企業の戦略的SWOT分析
    NxStage Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ascent Solar Technologies Inc (ASTI):企業の財務・戦略的SWOT分析
    Ascent Solar Technologies Inc (ASTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TUI AG (TUI1):企業の財務・戦略的SWOT分析
    TUI AG (TUI1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Aravive Inc (VSAR):企業の財務・戦略的SWOT分析
    Summary Aravive Inc(Aravive) formerly known as Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GH …
  • Gebr. Heinemann SE & Co. KG:戦略・SWOT・企業財務分析
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Medical University of Vienna-製薬・医療分野:企業M&A・提携分析
    Summary Medical University of Vienna (MUV) is a medical research institute that offers educational services. The institute provides research and education services in the field of medical science. Its research services include project submission, clinical and preclinical studies, research funding, b …
  • Keyera Corp (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Keyera Corp (Keyera) is a midstream oil and gas company. The company offers services such as processing, storage, transportation and marketing of oil and natural gas. It owns and operates raw gas gathering pipelines and processing plants, which collect and process raw natural gas, remove was …
  • Gentex Corporation:企業の戦略・SWOT・財務情報
    Gentex Corporation - Strategy, SWOT and Corporate Finance Report Summary Gentex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CSL Ltd (CSL):製薬・医療:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析
    Summary UMN Pharma Inc (UMN Pharma), a subsidiary of Shionogi Inc, is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s pipeline products include UMN-101 for the treatment of Recombinant seasonal influenza vaccine; UMN-102 for rec …
  • Swarovski AG:企業の戦略・SWOT・財務分析
    Swarovski AG - Strategy, SWOT and Corporate Finance Report Summary Swarovski AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • W.W. Grainger, Inc.:企業の戦略・SWOT・財務分析
    W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report Summary W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aggreko Plc (AGK):企業の財務・戦略的SWOT分析
    Aggreko Plc (AGK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆